Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC‐Pf7, a Pox‐Vectored, Multiantigen, Multistage Vaccine Candidate forPlasmodium falciparumMalaria
Authors:
- Christian F. OckenhouseCOChristian F. Ockenhouse
- Pei‐Fang SunPSPei‐Fang Sun
- David E. LanarDLDavid E. Lanar
- Bruce T. WelldeBWBruce T. Wellde
- B. Ted HallBHB. Ted Hall
- Kent KesterKKKent Kester
- Jose A. StouteJSJose A. Stoute
- Alan MagillAMAlan Magill
- Urszula KrzychUKUrszula Krzych
- Linda FarleyLFLinda Farley
- Robert A. WirtzRWRobert A. Wirtz
- Jerald C. SadoffJSJerald C. Sadoff
- 1 June 1998
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 177 (6) , 1664-1673